CONSEJO SUPERIOR

REFERENCE LIST

1. Harding, F. A., McArthur, J. G., Gross, J. A., Raulet, D. H. & Allison, J. P. CD28- mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature 356, 607-609, doi:10.1038/356607a0 (1992). 2. Koulova, L., Clark, E. A., Shu, G. & Dupont,

B. The CD28 ligand B7/BB1 provides costimulatory signal for alloactivation of CD4+ T cells. The Journal of experimental medicine173, 759-762 (1991).

3. Krummel, M. F. & Allison, J. P. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. The Journal of experimental medicine182, 459-465 (1995).

4. Ise, W. et al. CTLA-4 suppresses the pathogenicity of self antigen-specific T cells by cell-intrinsic and cell-extrinsic mechanisms. Nature immunology 11, 129-135, doi:10.1038/ni.1835 (2010). 5. Wing, K. et al. CTLA-4 control over Foxp3+

regulatory T cell function. Science 322, 271-275, doi:322/5899/271 [pii];10.1126/ science.1160062 [doi] (2008).

6. Qureshi, O. S. et al. Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4. Science 332, 600-603, doi:science.1202947 [pii];10.1126/ science.1202947 [doi] (2011).

7. Orban, T. et al. Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial. Lancet 378, 412-419, doi:10.1016/S0140-6736 (11)60886-6 (2011).

8. Barrett, J. C. et al. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nature Genetics 41, 703-707, doi:Doi 10.1038/Ng.381 (2009).

9. Smyth, D. J. et al. Shared and distinct genetic variants in type 1 diabetes

and celiac disease. The New England journal of medicine 359, 2767-2777, doi:10.1056/NEJMoa0807917 (2008). 10. Stahl, E. A. et al. Genome-wide

association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nature Genetics 42, 508-514, doi:10.1038/ng.582 (2010).

11. Rueda, B. et al. CTLA4/CT60 polymorphism is not relevant in susceptibility to autoimmune inflammatory intestinal disorders. Human immunology66, 321-325, doi:10.1016/j. humimm.2004.11.005 (2005).

12. Chen, Z. et al. CTLA4 -1661A/G and 3’UTR long repeat polymorphisms are associated with ulcerative colitis and influence CTLA4 mRNA and protein expression. Genes and immunity 11, 573-583, doi:10.1038/ gene.2010.16 (2010).

13. Zhernakova, A. et al. CTLA4 is differentially associated with autoimmune diseases in the Dutch population. Human genetics118, 58-66, doi:10.1007/s00439-005-0006-z (2005). 14. Ligers, A., Teleshova, N., Masterman, T.,

Huang, W. X. & Hillert, J. CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms. Genes and immunity2, 145-152, doi:DOI 10.1038/ sj.gene.6363752 (2001).

15. Ueda, H. et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423, 506-511, doi:10.1038/nature01621 [doi];nature01621 [pii] (2003).

16. Hao, S. & Baltimore, D. The stability of mRNA influences the temporal order of the induction of genes encoding inflammatory molecules. Nature immunology 10, 281-288, doi:10.1038/ ni.1699 (2009).

17. Anderson, P. Post-transcriptional control of cytokine production. Nature

5

ni1584 (2008).

18. de Jong, V. M. et al. Post-transcriptional control of candidate risk genes for type 1 diabetes by rare genetic variants. Genes and immunity 14, 58-61, doi:10.1038/ gene.2012.38 (2013).

19. Morahan, G. et al. Linkage disequilibrium of a type 1 diabetes susceptibility locus with a regulatory IL12B allele.

Nature Genetics 27, 218-221,

doi:10.1038/84872 (2001).

20. Roep, B. O. et al. T-cell reactivity to 38 kD insulin-secretory-granule protein in patients with recent-onset type 1 diabetes. Lancet337, 1439-1441 (1991). 21. Lindstein, T., June, C. H., Ledbetter, J. A.,

Stella, G. & Thompson, C. B. Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. Science244, 339-343 (1989). 22. Gough, S. C., Walker, L. S. & Sansom,

D. M. CTLA4 gene polymorphism and autoimmunity. Immunological reviews 204, 102-115, doi:10.1111/j.0105- 2896.2005.00249.x (2005).

23. Mayans, S. et al. CT60 genotype does not affect CTLA-4 isoform expression despite association to T1D and AITD in northern Sweden. BMC medical genetics 8, 3, doi:10.1186/1471-2350-8-3 (2007). 24. Purohit, S. et al. Lack of correlation

between the levels of soluble cytotoxic T-lymphocyte associated antigen-4

(CTLA-4) and the CT-60 genotypes.

Journal of autoimmune diseases 2, 8, doi:10.1186/1740-2557-2-8 (2005). 25. Atabani, S. F. et al. Association of

CTLA4 polymorphism with regulatory T cell frequency. European journal

of immunology 35, 2157-2162,

doi:10.1002/eji.200526168 (2005). 26. Esposito, L. et al. Investigation of

Soluble and Transmembrane CTLA-4 Isoforms in Serum and Microvesicles.

J Immunol 193, 889-900, doi:10.4049/ jimmunol.1303389 (2014).

27. Vijayakrishnan, L. et al. An autoimmune disease-associated CTLA-4 splice variant lacking the B7 binding domain signals negatively in T cells. Immunity.20, 563-575, doi:S1074761304001104 [pii] (2004). 28. Araki, M. et al. Genetic evidence that

the differential expression of the ligand- independent isoform of CTLA-4 is the molecular basis of the Idd5.1 type 1 diabetes region in nonobese diabetic mice. J Immunol 183, 5146-5157, doi:10.4049/jimmunol.0802610 (2009). 29. Gu, M. et al. Identification of CTLA-4

isoforms produced by alternative splicing and their association with myasthenia gravis. Clin Immunol128, 374-381, doi: DOI 10.1016/j.clim.2008.05.006 (2008). 30. Dudbridge, F. Likelihood-based

association analysis for nuclear families and unrelated subjects with missing genotype data. Human heredity 66, 87-98, doi:10.1159/000119108 (2008).

Supplementary Figure 1. CTLA4 (AT)n does not affect CTLA-4 mRNA decay. Jurkat cells transduced

with a vector containing an (AT)₇ (open circles) or (AT)₂₈ (black circles) element were treated with Actinomycin D and GFP mRNA was analysed at different time points. Cells were harvested at different time points and qRT-PCR analysis for GFP was performed at and normalized for the housekeeping gene OAZ1 in triplicates. Results are shown as mean ± S.E.M.

SUPPLEMENTARY DATA